|Table of Contents|

Application analysis of domestic Toumai endoscopic surgical robot assisted radical resection of right colon cancer

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2024 07
Page:
1283-1287
Research Field:
Publishing date:

Info

Title:
Application analysis of domestic Toumai endoscopic surgical robot assisted radical resection of right colon cancer
Author(s):
YANG Guoyuan1; PENG Yiyun1; MA Diaolong2; HU Ming2; YANG Jing2; MA Yuntao2
1.The First Clinical Medical College，Gansu University of Chinese Medicine，Gansu Lanzhou 730000，China；2.Department of the First Ward of General Surgery，Gansu Provincial People’s Hospital，Gansu Lanzhou 730000，China.
Keywords:
Toumai endoscopic surgical robot; colon cancer; radical resection of right colon cancer; complete mesocolic excision
PACS:
R735.3+5
DOI:
10.3969/j.issn.1672-4992.2024.07.017
Abstract:
Objective:To firstly explore the Toumai endoscopic surgical robot-assisted the safety and feasibility radical resection of right colon cancer.Methods:Clinical data of 6 patients with right colon cancer admitted to the First Ward of General Surgery Department of Gansu Provincial People’s Hospital from April to June 2022 were collected.There were 4 males and 2 female,the median age was 57 years,and the range was 37～68 years.Patients were performed by Toumai endoscopic surgical robot-assisted radical resection for right colon cancer,namely D3+complete mesocolic excision of the right colon.Results:All the 6 patients completed the operation successfully.The average operation time was 204.16 min,the intraoperative blood loss was 108.31 mL,the postoperative ambulation time was 3.16 days,the postoperative gastrointestinal function recovery time was 4.16 days,the mean time of liquid diet intake was 5 days,the tube drainage time was 8 days,the total number of lymph node dissection was 23.33 pieces,and the postoperative hospital stay was 9.5 days.No device-related adverse events occurred during and after the operation.All the 6 patients received systemic intravenous chemotherapy with FOLFOX for 6～8 cycles.The 1-year overall survival rate was 100%.Conclusion:Toumai endoscopic surgical robot-assisted radical resection of right colon canceris safe and feasible,with good clinical efficacy.The robotic system is expected to become the main means of radical resection of colon cancer in China.

References:

[1] SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］.CA Cancer J Clin,2021,71(3):209-249.
[2] SIEGEL RL,MILLER KD,WAGLE NS,et al.Cancer statistics,2023［J］.CA Cancer J Clin,2023,73(1):17-48.
[3] FERLAY J,COLOMBET M,SOERJOMATARAM I,et al.Estimating the global cancer incidence and mortality in 2018:GLOBOCAN sources and methods［J］.Int J Cancer,2019,144(8):1941-1953.
[4] 姚宏伟,李心翔,崔龙,等.中国结直肠癌手术病例登记数据库2022年度报告：一项全国性登记研究［J］.中国实用外科杂志,2023,43(01):93-99.YAO HW,LI XX,CUI L,et al.China colorectal cancer surgery registry 2022 annual report:a national registry study［J］.Chinese Journal of Practical Surgery,2023,43(01):93-99.
[5] 朱鹏程,李明,缪文忠,等.全腹腔镜右半结肠切除术治疗右半结肠癌的前瞻性对照研究［J］.现代肿瘤医学,2022,30(14):2553-2557.ZHU PC,LI M,MIU WZ,et al.A prospective controlled study of total laparoscopic right hemicolectomy for right colon cancer［J］.Modern Oncology,2022,30(14):2553-2557.
[6] BERNHOFF R,SJOVALL A,BUCHLI C,et al.Complete mesocolic excision in right-sided colon cancer does not increase severe short-term postoperative adverse events［J］.Colorectal Dis,2018,20(5):383-389.
[7] WEBER PA,MEROLA S,WASIELEWSKI A,et al.Telerobotic-assisted laparoscopic right and sigmoid colectomies for benign disease［J］.Dis Colon Rectum,2002,45(12):1689-1694.
[8] HASHIZUME M,SHIMADA M,TOMIKAWA M,et al.Early experiences of endoscopic procedures in general surgery assisted by a computer-enhanced surgical system［J］.Surg Endosc,2002,16(8):1187-1191.
[9] PINAR I,FRANSGAARD T,THYGESEN LC,et al.Long-term outcomes of robot-assisted surgery in patients with colorectal cancer［J］.Ann Surg Oncol,2018,25(13):3906-3912.
[10] SOLAINI L,BAZZOCCHI F,CAVALIERE D,et al.Robotic versus laparoscopic right colectomy:an updated systematic review and meta-analysis［J］.Surg Endosc,2018,32(3):1104-1110.
[11] 余佩武,李政焰.机器人胃癌手术的未来前景［J］.中华胃肠外科杂志,2022，25(08):682-685.YU PW,LI ZY.Future prospects of robotic gastric cancer surgery［J］.Chin J Gastrointestinal Surgery,2022,25(08):682-685.
[12] 杨婧,李祖曦,狐鸣,等.国产图迈内窥镜手术系统辅助下胃癌根治术9例的临床分析［J］.中华普通外科杂志,2022，37(11):850-851.YANG J,LI ZX,HU M,et al.Clinical analysis of 9 cases of radical gastrectomy assisted by domestic Toumai endoscopic surgical system［J］.Chin J Gen Surg,2022,37(11):850-851.
[13] 黄显斌,狐鸣,蔡辉,等.程序化达芬奇机器人“3+2”模式“七步法”远端胃癌根治术［J］.中国肿瘤临床,2022,49(03):124-128.HUANG XB,HU M,CAI H,et al.Programmed Da Vinci robotic "3+2" mode "seven-step" distal gastrectomy for gastric cancer［J］.Chinese Journal of Clinical Oncology,2022,49(03):124-128.
[14] 狐鸣,马雕龙,张文涛,等.机器人“3+2”模式胃肠手术Trocar布置方法的总结与实践［J］.中华普通外科杂志,2023,38(08)：589-594.HU M,MA DL,ZHANG WT,et al.To summarize and practice the layout of robotic Trocar in "3+2" mode gastrointestinal surgery［J］.Chin J Gen Surg,2023,38(08)：589-594.
[15] 连玉贵,周全博,段小飞,等.尾侧联合肠系膜上静脉优先入路机器人辅助下全结肠系膜切除治疗右半结肠癌的效果［J］.郑州大学学报(医学版),2021,56(03):341-345.LIAN YG,ZHOU QB,DUAN XF,et al.To evaluate the effect of robot-assisted complete mesocolic excision with caudal combined superior mesenteric vein first approach in the treatment of right colon cancer［J］.Journal of Zhengzhou University(Medical Edition),2021,56(03):341-345.
[16] 冯青阳,何国栋,许剑民.机器人结直肠癌手术中国专家共识(2020版)［J］.中国实用外科杂志,2021,41(01):12-19.FENG QY,HE GD,XU JM.Chinese expert consensus on robotic colorectal cancer surgery(2020 edition) ［J］.Chin J Pract Surg,2021,41(01):12-19.
[17] 中华人民共和国国家卫生健康委员会医政医管局,中华医学会肿瘤学分会.中国结直肠癌诊疗规范(2020年版)［J］.中国实用外科杂志,2020,40(06):601-625.Medical Administration Bureau of National Health Commission of the People’s Republic of China,Oncology Society of Chinese Medical Association.Chinese guidelines for diagnosis and treatment of colorectal cancer(2020 edition) ［J］.Chin J Pract Surg,2020,40(06):601-625.
[18] BENSON AB,VENOOK AP,AL-HAWARY MM,et al.Colon cancer,version 2.2021,NCCN clinical practice guidelines in oncology［J］.J Natl Compr Canc Netw,2021,19(3):329-359.
[19] 叶勇,张秋杰,胡康,等.达芬奇机器人手术系统辅助和腹腔镜辅助全结肠系膜切除术治疗右半结肠癌的疗效分析［J］.中华消化外科杂志,2021,20(05):535-542.YE Y,ZAHNG QJ,HU K,et al.To compare the efficacy of Da Vinci robot-assisted and laparoscopic-assisted complete mesocolic excision for right colon cancer［J］.Chinese Journal of Digestive Surgery,2021,20(05):535-542.
[20] 张靖,路璐,王晓楠,等.达芬奇机器人与单孔、三孔胸腔镜肺癌根治术的临床疗效比较 ［J］.现代肿瘤医学,2020,28(12):2046-2049.ZHANG J,LU L,WANG XN,et al.Da Vinci robotic surgery,uniportal and three portal video-assisted thoracic surgery for radical lung cancer:A comparative study［J］.Modern Oncology，2020,28(12):2046-2049.
[21] HUETTNER F,RAWLINGS AL,MCVAY WB,et al.Robot-assisted laparoscopic colectomy:70 cases-one surgeon［J］.J Robot Surg,2008,2(4):227-234.
[22] D’ ANNIBALE A,PERNAZZA G,MORPURGO E,et al.Robotic right colon resection:evaluation of first 50 consecutive cases for malignant disease［J］.Ann Surg Oncol,2010,17(11):2856-2862.
[23] 罗华星,唐波,张超,等.达芬奇机器人手术系统辅助右半结肠癌根治术的临床疗效［J］.中华消化外科杂志,2019,18(5):472-477.LUO HX,TANG B,ZHANG C,et al.To evaluate the clinical efficacy of Da Vinci robot-assisted right hemicolectomy for colon cancer ［J］.Chinese Journal of Digestive Surgery,2019,18(5):472-477.
[24] 黄佳,田禹,陆佩吉,等.国产图迈微创腔镜手术机器人辅助右肺上叶切除两例［J］.中国胸心血管外科临床杂志,2022,29(04):519-523.HUANG J,TIAN Y,LU PJ,et al.Two cases of right upper lobectomy assisted by domestic Toumai minimally invasive endoscopic surgical robot were reported ［J］.Chinese Journal of Cardiothoracic Surgery,2022,29(04):519-523.
[25] BOKHARI MB,PATEL CB,RAMOS-VALADEZ DI,et al.Learning curve for robotic-assisted laparoscopic colorectal surgery［J］.Surg Endosc,2011,25(3):855-860.

Memo

Memo:
甘肃省自然科学基金(编号：22JR85RA663)；甘肃省人民医院院内科研基金(编号：22GSSYC-15)
Last Update: 2024-02-29